{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:49:04Z","timestamp":1782391744588,"version":"3.54.5"},"reference-count":30,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Stroke"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The relationship between cannabis use and stroke prevalence remains incompletely characterized, with most studies limited by binary exposure classification. We examined the frequency-dependent association of cannabis use and stroke prevalence by subtype in a large, diverse national cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Our primary aim was to explore the relationship between cannabis use frequency and the adjusted prevalence of ischemic and hemorrhagic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We conducted a cross-sectional analysis of 122,767 adults from the National Institutes of Health (NIH)\n                      <jats:italic toggle=\"yes\">All of Us<\/jats:italic>\n                      Research Program who completed lifestyle surveys between 2017-2022. Cannabis use frequency was stratified into five categories: never, once or twice, monthly, weekly, and daily. Ischemic and hemorrhagic stroke diagnoses were identified using International Classification of Diseases (ICD) 9 and 10 codes. Multivariable logistic regression models were adjusted for age, sex, race\/ethnicity, obesity, type 2 diabetes, alcohol, and tobacco use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 122,767 participants, 2,765 (2.3%) had a history of stroke. After multivariable adjustment, a significant frequency-dependent association was found for ischemic stroke; compared to never-users, \u201conce or twice\u201d use was associated with a 10% increased odds (adjusted odds ratio (aOR) = 1.10, confidence interval (CI) = 0.95\u20131.26), monthly use with a 3% reduced odds (aOR = 0.97, CI = 0.73\u20131.29), weekly use with a 45% increased odds (aOR = 1.45, 95% CI = 1.19-1.77), and daily use with a 48% increased odds (aOR = 1.48, 95% CI = 1.26\u20131.74). In contrast, the odds of hemorrhagic stroke were elevated across all frequencies of cannabis use, with the highest odds observed in monthly users (aOR = 1.74, 95% CI = 1.21\u20132.51). These subtype-specific associations contributed to an overall increased odds of any stroke for weekly (aOR = 1.39) and daily (aOR = 1.44) users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this large, nationally representative study, cannabis use was associated with stroke through two distinct, subtype-specific patterns. Odds of ischemic stroke demonstrated a clear dose-response relationship concentrated among frequent (weekly or daily) users, while odds of hemorrhagic stroke were elevated across all frequencies of use. These findings highlight the need to incorporate detailed cannabis use assessment into routine cerebrovascular risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17474930251396481","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:49:03Z","timestamp":1762346943000},"page":"815-826","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Is the association of cannabis use and stroke frequency-dependent: A cross-sectional analysis of the NIH all of us research program"],"prefix":"10.1177","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6933-0745","authenticated-orcid":false,"given":"Ethan DL","family":"Brown","sequence":"first","affiliation":[{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Lake Success, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnabas","family":"Obeng-Gyasi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Allegheny Health Network, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Won","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Allegheny Health Network, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3330-455X","authenticated-orcid":false,"given":"Daniel","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladine A","family":"Elsamadicy","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Northwell Health, New Hyde Park, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Luther","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Allegheny Health Network, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Libman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwell Health, New Hyde Park, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwell Health, New Hyde Park, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G","family":"White","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Northwell Health, New Hyde Park, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"Tsao CW Aday AW Almarzooq ZI et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 2023; 147: e93. https:\/\/doi.org\/10.1161\/CIR.0000000000001123","DOI":"10.1161\/CIR.0000000000001137"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Global regional national burden of stroke its risk factors. 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20: 795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"e_1_3_3_4_2","unstructured":"World Drug Report 2021. UN Off Drugs Crime n.d. www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2021.html (accessed June 28 2025)"},{"key":"e_1_3_3_5_2","unstructured":"Results from the 2019 National Survey on Drug Use and Health (NSDUH): Key substance use and mental health indicators in the United States SAMHSA Library n.d. https:\/\/library.samhsa.gov\/product\/results-2019-national-survey-drug-use-and-health-nsduh-key-substance-use-and-mental-health (accessed June 28 2025)."},{"key":"e_1_3_3_6_2","unstructured":"State Medical Cannabis Laws n.d. https:\/\/www.ncsl.org\/health\/state-medical-cannabis-laws (accessed June 28 2025)"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","unstructured":"Storck W Elbaz M Vindis C et al. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart Br Card Soc 2025:heartjnl-2024-325429. https:\/\/doi.org\/10.1136\/heartjnl-2024-325429","DOI":"10.1136\/heartjnl-2024-325429"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Abdullah FT Al-Dulaimi AA Vaghela K et al. Cannabis use in different ethnicity\/race populations and risk of ischemic stroke: a systematic review and meta-analysis. J Ethn Subst Abuse 2025: 1\u201319. https:\/\/doi.org\/10.1080\/15332640.2025.2505059","DOI":"10.1080\/15332640.2025.2505059"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Liu D Yang L Liu P Wang Y Gao L. Impact of cannabis abuse on the occurrence of stroke in young people: a systematic review and meta-analysis. Front Neurol 2024; 15. https:\/\/doi.org\/10.3389\/fneur.2024.1426023","DOI":"10.3389\/fneur.2024.1426023"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Falkstedt D Wolff V Allebeck P et al. Cannabis tobacco alcohol use and the risk of early stroke: a population-based cohort study of 45\u2009000 Swedish men. Stroke 2017; 48: 265\u2013270. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015565","DOI":"10.1161\/STROKEAHA.116.015565"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Dutta T Ryan KA Thompson O et al. Marijuana use and the risk of early ischemic stroke: the stroke prevention in young adults study. Stroke 2021; 52: 3184\u20133190. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032811","DOI":"10.1161\/STROKEAHA.120.032811"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Jeffers AM Glantz S Byers AL et al. Association of cannabis use with cardiovascular outcomes among US adults. J Am Heart Assoc 2024; 13: e030178. https:\/\/doi.org\/10.1161\/JAHA.123.030178","DOI":"10.1161\/JAHA.123.030178"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Page RL Allen LA Kloner RA et al. Medical Marijuana recreational cannabis and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2020; 142: e131\u2013e152. https:\/\/doi.org\/10.1161\/CIR.0000000000000883","DOI":"10.1161\/CIR.0000000000000883"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","unstructured":"DeFilippis EM Bajaj NS Singh A et al. Marijuana use in patients with cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol 2020; 75: 320\u2013332. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.025","DOI":"10.1016\/j.jacc.2019.11.025"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","unstructured":"All of Us Research Program Investigators. The \u201cAll of Us\u201d research program. N Engl J Med 2019; 381: 668\u2013676. https:\/\/doi.org\/10.1056\/NEJMsr1809937","DOI":"10.1056\/NEJMsr1809937"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Kaombe TM Hamuza GA. Impact of ignoring sampling design in the prediction of binary health outcomes through logistic regression: evidence from Malawi demographic and health survey under-five mortality data; 2000-2016. BMC Public Health 2023; 23: 1674. https:\/\/doi.org\/10.1186\/s12889-023-16544-4","DOI":"10.1186\/s12889-023-16544-4"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Hemachandra D McKetin R Cherbuin N Anstey KJ. Heavy cannabis users at elevated risk of stroke: evidence from a general population survey. Aust N Z J Public Health 2016; 40: 226\u2013230. https:\/\/doi.org\/10.1111\/1753-6405.12477","DOI":"10.1111\/1753-6405.12477"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Parekh T Pemmasani S Desai R. Marijuana use among young adults (18-44 Years of Age) and risk of stroke: a behavioral risk factor surveillance system survey analysis. Stroke 2020; 51: 308\u2013310. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027828","DOI":"10.1161\/STROKEAHA.119.027828"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"Mohammadi L Navabzadeh M Jim\u00e9nez-T\u00e9llez N et al. Association of endothelial dysfunction with chronic marijuana smoking and THC-edible use. JAMA Cardiol 2025: e251399. https:\/\/doi.org\/10.1001\/jamacardio.2025.1399","DOI":"10.1001\/jamacardio.2025.1399"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","unstructured":"Pacher P Steffens S Hask\u00f3 G Schindler TH Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good the bad and the ugly. Nat Rev Cardiol 2018; 15: 151\u2013166. https:\/\/doi.org\/10.1038\/nrcardio.2017.130","DOI":"10.1038\/nrcardio.2017.130"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"Latif Z Garg N. The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use. J Clin Med 2020; 9: 1925. https:\/\/doi.org\/10.3390\/jcm9061925","DOI":"10.3390\/jcm9061925"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Gou R Luo C Liang X et al. Elderly stroke burden: a comprehensive global study over three decades. Front Aging 2025; 6: 1489914. https:\/\/doi.org\/10.3389\/fragi.2025.1489914","DOI":"10.3389\/fragi.2025.1489914"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","unstructured":"Ghasemiesfe M Ravi D Casino T Korenstein D Keyhani S. Acute cardiovascular effects of marijuana use. J Gen Intern Med 2020; 35: 969\u2013974. https:\/\/doi.org\/10.1007\/s11606-019-05235-9","DOI":"10.1007\/s11606-019-05235-9"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","unstructured":"Wolff V Jouanjus E. Strokes are possible complications of cannabinoids use. Epilepsy Behav 2017; 70: 355\u2013363. https:\/\/doi.org\/10.1016\/j.yebeh.2017.01.031","DOI":"10.1016\/j.yebeh.2017.01.031"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","unstructured":"Short K Emsley HCA. Illicit drugs and reversible cerebral vasoconstriction syndrome. Neurohospitalist 2021; 11: 40\u201344. https:\/\/doi.org\/10.1177\/1941874420953051","DOI":"10.1177\/1941874420953051"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","unstructured":"Behrouz R Birnbaum L Grandhi R et al. Cannabis use and outcomes in patients with aneurysmal subarachnoid hemorrhage. Stroke 2016; 47: 1371\u20131373. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013099","DOI":"10.1161\/STROKEAHA.116.013099"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","unstructured":"Ogunbiyi MO Hindocha C Freeman TP et al. Acute and chronic effects of \u03949-tetrahydrocannabinol (THC) on cerebral blood flow: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2020; 101: 109900. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109900","DOI":"10.1016\/j.pnpbp.2020.109900"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","unstructured":"Chye DM Sampaio Rodrigues T Quarto LJG et al. Cannabis use and atrial arrhythmias: a systematic review and meta-analysis of large populational studies. Heart Rhythm 2025; S1547-5271. https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.062","DOI":"10.1016\/j.hrthm.2025.05.062"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","unstructured":"Carter C Laviolette L Bietar B et al. Cannabis cannabinoids and stroke: increased risk or potential for protection\u2014a narrative review. Curr Issues Mol Biol 2024; 46: 3122\u20133133. https:\/\/doi.org\/10.3390\/cimb46040196","DOI":"10.3390\/cimb46040196"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","unstructured":"Chandra S Radwan MM Majumdar CG et al. New trends in cannabis potency in USA and Europe during the last decade (2008-2017). Eur Arch Psychiatry Clin Neurosci 2019; 269: 5\u201315. https:\/\/doi.org\/10.1007\/s00406-019-00983-5","DOI":"10.1007\/s00406-019-00983-5"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","unstructured":"Hall W Lynskey M. Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiat 2020; 19: 179\u2013186. https:\/\/doi.org\/10.1002\/wps.20735","DOI":"10.1002\/wps.20735"}],"container-title":["International Journal of Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17474930251396481","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17474930251396481","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17474930251396481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:50:11Z","timestamp":1782388211000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17474930251396481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/17474930251396481"],"URL":"https:\/\/doi.org\/10.1177\/17474930251396481","relation":{},"ISSN":["1747-4930","1747-4949"],"issn-type":[{"value":"1747-4930","type":"print"},{"value":"1747-4949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}